{"title": "Programas de Tribunales de Tratamiento de drogas que tratan delitos relacionados con las drogas, para reducir la reincidencia", "author": "Best practice portal main page", "url": "https://www.emcdda.europa.eu/best-practice/evidence-summaries/drug-court-programmes-reduce-recidivism_es", "hostname": "europa.eu", "description": "En una revisi\u00f3n sistem\u00e1tica (Mitchell et al., 2012, 154 estudios) se hall\u00f3 que los Programas de Tribunales de Tratamiento de drogas eran efectivos en:", "sitename": "www.emcdda.europa.eu", "date": "2023-09-19", "id": null, "license": null, "body": null, "comments": "", "commentsbody": null, "raw_text": null, "text": "[\nBest practice portal main page\n](/best-practice)\nProgramas de Tribunales de Tratamiento de drogas que tratan delitos relacionados con las drogas, para reducir la reincidencia\nSummary of the evidence\nEn una revisi\u00f3n sistem\u00e1tica (Mitchell et al., 2012, 154 estudios) se hall\u00f3 que los Programas de Tribunales de Tratamiento de drogas eran efectivos en:\n- la reducci\u00f3n de la reincidencia a los tres a\u00f1os de seguimiento de los programas de Tribunales de Tratamiento de drogas para adultos (3 estudios; el tama\u00f1o del efecto medio es an\u00e1logo a una ca\u00edda en la reincidencia del 50% para los no participantes para aproximadamente un 38% para los participantes)\n- la reducci\u00f3n de la reincidencia por conducir ebrio (DWI) (4 estudios \u2013 3 hallaron reducciones importantes en la reincidencia, sin embargo, 1 evaluaci\u00f3n experimental encontr\u00f3 un efecto negativo)\n- la reducci\u00f3n de la reincidencia en estos Juzgados juveniles, aunque con un tama\u00f1o de efecto menor (el tama\u00f1o del efecto medio es an\u00e1logo a una ca\u00edda en la reincidencia del 50% para los no participantes y de aproximadamente el 43,5% para los participantes)", "language": null, "image": null, "pagetype": null, "links": ["#main-content", "/", "#block-block-menu-quick-links-menu", "/activities_es", "/activities/campaigns_es", "https://www.emcdda.europa.eu/topics/cannabis-policy", "/topics/covid-19_es", "/document-library_es", "https://www.emcdda.europa.eu/drug-profiles", "/darknet_es", "/publications/topic-overviews/eu-early-warning-system_es", "http://www.espad.org", "/publications/eu-drug-markets_es", "/publications/european-drug-report/2023_es", "/publications/health-and-social-responses-a-european-guide_es", "https://www.emcdda.europa.eu/activities/key-indicators", "https://www.lisbonaddictions.eu", "/media-library_es", "https://www.emcdda.europa.eu/about/partners", "/publications/topic-overviews/policy-evaluation_es", "/data/stats2021_es", "https://wayback.archive-it.org/12090/*/https://www.emcdda.europa.eu/", "http://www.facebook.com/emcdda", "https://twitter.com/emcdda", "http://www.linkedin.com/company/emcdda", "http://www.youtube.com/user/emcddatube", "/news/home/rss.xml", "/best-practice/evidence-summaries/drug-court-programmes-reduce-recidivism_en", "#mainNavbar", "/index_es", "/index_es", "#", "/data_en", "/data_en", "/data_en", "/data/stats2023/gps_en", "/data/stats2023/drd_en", "/data/stats2023/drid_en", "/data/stats2023/pdu_en", "/data/stats2023/tdi_en", "/data/stats2023/szr_en", "/data/stats2023/ppp_en", "/data/stats2023/dup_en", "/data/stats2023/dlo_en", "/data/stats2023/hsr_en", "/data/stats2023/drug-checking_en", "/data/stats2023/hospital-emergencies_en", "/data/stats2023/syringe-residues_en", "/publications/html/pods/waste-water-analysis_en", "/data/data-catalogue_en", "#", "/countries_en", "/countries_en", "/countries_en", "/about/partners/reitox/austria_en", "/about/partners/reitox/belgium_en", "/about/partners/reitox/bulgaria_en", "/about/partners/reitox/croatia_en", "/about/partners/reitox/cyprus_en", "/about/partners/reitox/czechia_en", "/about/partners/reitox/denmark_en", "/about/partners/reitox/estonia_en", "/about/partners/reitox/finland_en", "/about/partners/reitox/france_en", "/about/partners/reitox/germany_en", "/about/partners/reitox/greece_en", "/about/partners/reitox/hungary_en", "/about/partners/reitox/ireland_en", "/about/partners/reitox/italy_en", "/about/partners/reitox/latvia_en", "/about/partners/reitox/lithuania_en", "/about/partners/reitox/luxembourg_en", "/about/partners/reitox/malta_en", "/about/partners/reitox/netherlands_en", "/about/partners/reitox/norway_en", "/about/partners/reitox/poland_en", "/about/partners/reitox/portugal_en", "/about/partners/reitox/romania_en", "/about/partners/reitox/slovakia_en", "/about/partners/reitox/slovenia_en", "/about/partners/reitox/spain_en", "/about/partners/reitox/sweden_en", "/about/partners/reitox/t%C3%BCrkiye_en", "/countries", "#", "/topics_en", "/topics_en", "/topics_en", "/content/alternatives-coercive-sanctions_en", "/topics/cannabis_en", "/topics/cannabis-policy_en", "/topics/cocaine_en", "/topics/darknet-and-drugs_en", "/topics/drug-checking_en", "/topics/drug-consumption-facilities_en", "/topics/drug-markets_en", "/topics/drug-related-deaths_en", "/topics/drug-related-infectious-diseases_en", "/topics/drugs-and-driving_en", "/topics/european-web-survey-on-drugs_en", "/topics/gender-and-drugs_en", "/topics/harm-reduction_en", "/topics/heroin_en", "/topics/hospital-emergencies_en", "/topics/law_en", "/topics/naloxone_en", "/topics/nps_en", "/topics/prevalence-and-patterns-of-drug-use_en", "/topics/prevention_en", "/topics/prison_en", "/topics/production-of-drugs_en", "/topics/synthetic-cannabinoids_en", "/topics/synthetic-cathinones_en", "/topics/escape_en", "/topics/treatment_en", "/topics/wastewater_en", "/topics/young-people_en", "/topics_en", "#", "/best-practice_en", "/best-practice_en", "/best-practice_en", "/best-practice/evidence-summaries_en", "/best-practice/european-prevention-curriculum-eupc_en", "/best-practice/evaluation-instruments-bank-eib_en", "/best-practice/guidelines_en", "/best-practice/xchange_en", "/publications/health-and-social-responses-a-european-guide_en", "http://hntinfo.eu/", "/best-practice/european-prevention-curriculum-eupc/list-of-trainers_en", "https://plato.emcdda.europa.eu/index.php/en/", "/toolkit/prevention-toolkit_en", "http://eepurl.com/5rLmf", "#", "/activities_en", "/activities_en", "/publications/topic-overviews/eu-early-warning-system_en", "/topics/key-indicators_en", "/publications/topic-overviews/policy-evaluation_en", "/activities/promoting-hcv-hepatitis-c-virus-testing-and-linkage-care-drugs-services_en", "/activities/european-web-survey-on-drugs_en", "/about/partners/reitox_en", "/about/partners/cc/ipa8_en", "/activities/eu4md-ii", "/activities/emcdda4georgia_en", "/activities/copolad_en", "/activities/empact-keeping-eu-safe_en", "#", "/publications_en", "/publications_en", "/publications_en", "/publications_en", "/document-library_en", "/media-library_en", "/publications/european-drug-report/2023_en", "/publications/health-and-social-responses-a-european-guide_en", "/publications/eu-drug-markets_en", "/publications/drug-profiles_en", "/publications-database_en", "/publications/technical-reports/captagon-trafficking-and-role-europe_en", "/publications/data-factsheet/syringe-residues-analysis-data-escape-project_en", "/publications/topic-overviews/frequently-asked-questions-faq-drug-overdose-deaths-europe_en", "/publications/mini-guides/catalogue/older-people-and-drugs-health-and-social-responses_en", "/publications/data-factsheet/european-drug-emergencies-network-euro-den-plus-data-and-analysis_en", "/publications/european-drug-report/2023/mdma_en", "/publications/european-drug-report/2023/heroin-and-other-opioids_en", "/publications/european-drug-report/2023/other-drugs_en", "#", "/events_en", "/event/2023/09/emcdda-visit-azerbaijan_en", "/event/2023/10/14th-euspr-conference-and-members%E2%80%99-meeting_en", "/event/2023/10/expert-meeting-drug-related-deaths-drd-2023_en", "/event/2023/11/x-international-conference-novel-psychoactive-substances-2023_en", "/events_es", "#", "/news", "/news", "/news", "/news", "/news/2023/eu4monitoring-drugs-ii-first-emcdda-visit-azerbaijan_en", "/news/2023/7/new-report-shows-europe-key-transhipment-area-captagon-bound-arabian-peninsula_en", "/news/2023/first-european-prevention-curriculum-training-course-english-caribbean-countries_en", "/news/2023/international-overdose-awareness-day-emcdda-answers-key-questions-drug-related-deaths_en", "/news/2023/worldhepatitisday-helping-beat-viral-hepatitis_en", "/news/2023/new-multi-city-syringe-analysis_en", "/news_en", "/news_en", "http://eepurl.com/diT6L1", "http://eepurl.com/ceqCET", "#", "/about_en", "/about_en", "/about_en", "/about/mission_en", "/about/organisation_en", "/activities_en", "/about/partners_en", "/about/jobs", "/about/procurement", "/about/contact_en", "/about/director_en", "/about/mb_en", "/about/sc_en", "/about/data-protection_en", "/html.cfm/index16161EN.html", "/about/sustainability-at-the-emcdda_en", null, "/index_es", "/best-practice_es", "/best-practice/evidence-summaries_es", "/best-practice/evidence-summaries", "http://eepurl.com/5rLmf ", "/best-practice", "https://www.campbellcollaboration.org/library/drug-courts-effects-on-criminal-offending.html", "/node/6379", "implementations_en", "/best-practice/evidence-summaries", "/best-practice/guidelines", "/best-practice/about_en", "/best-practice/about#collaborations", "/best-practice/about#collaborations", "/best-practice/about#collaborations", "/best-practice/about#collaborations", "/about_es", "https://twitter.com/emcdda", "http://www.facebook.com/emcdda", "https://www.instagram.com/emcdda", "http://www.linkedin.com/company/emcdda", "http://www.youtube.com/user/emcddatube", "/news/home/rss.xml", "/publications/subscribe", "/about/contact_es", "/about/contact", "/about/jobs", "/about/legal-notice", "/about/data-protection_en", "http://europa.eu", "#top"]}